Cell Size and Velocity of Injection are Major Determinants of the Safety of Intracarotid Stem Cell Transplantation

• Published in: Journal of cerebral blood flow and metabolism Vol. 33; no. 6; pp. 921 - 927
• Main Authors: Janowski, Miroslaw, Lyczek, Agatha, Engels, Charla, Xu, Jiadi, Lukomska, Barbara, Bulte, Jeff WM, Walczak, Piotr
• Format: Journal Article
• Language: English
• Published: London, England SAGE Publications 01.06.2013; Sage Publications Ltd; Nature Publishing Group
• Subjects: Animals; Brain - blood supply; Brain - pathology; Carotid Artery, Internal - surgery; Cell Count; Cell Size; Cells, Cultured; Cerebrovascular Circulation; Humans; Intracranial Embolism - etiology; Intracranial Embolism - pathology; Magnetic Resonance Imaging; Male; Mesenchymal Stem Cell Transplantation - adverse effects; Mesenchymal Stem Cell Transplantation - instrumentation; Mesenchymal Stem Cell Transplantation - methods; Mesenchymal Stromal Cells - cytology; Original; Rats; Rats, Sprague-Dawley; Stroke - etiology; Stroke - pathology; Vascular Access Devices; intracarotid injection; glial-restricted progenitors; stroke; mesenchymal stem cells; transplantation
• ISSN: 0271-678X; 1559-7016
• DOI: 10.1038/jcbfm.2013.32

Intracarotid transplantation has shown potential for efficient stem cell delivery to the brain. However, reported complications, such as compromised cerebral blood flow (CBF), prompted us to perform further safety studies. Glial-restricted precursors (GRPs) and mesenchymal stem cells (MSCs) were transplanted into the internal carotid artery of rats (n = 99), using a microcatheter. Magnetic resonance imaging was used to detect post-transplantation complications, including the development of stroke, for the following experimental variables: cell size, cell dose, cell infusion velocity, delay between artery occlusion and cell infusion, discordant versus concordant xenografting, and intracarotid transplantation with preserved versus compromised blood flow. Immunocompatibility and delayed infusion did not affect the number of complications. An infusion velocity over ≥1 mL/minute often resulted in stroke (27 out of 44 animals), even with an infusion of vehicle, whereas a lower velocity (0.2 mL/minute) was safe for the infusion of both vehicle and smaller cells (GRPs, diameter = 15 μm). Infusion of larger cells (MSCs, diameter = 25 μm) resulted in a profound decrease (75 ± 17%) in CBF. Stroke lesions occurred frequently (12 out of 15 animals) when injecting 2 × 106 MSCs, but not after lowering the dose to 1 × 106 cells. The present results show that cell size and infusion velocity are critical factors in developing safe protocols for intracarotid stem cell transplantation.